OTCMKTS:TRXDW TransEnterix (TRXDW) Stock Price, News & Analysis → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free TRXDW Stock Alerts $0.0011 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$0.0011▼$0.001150-Day Range N/A52-Week Range$0.0011▼$0.0011VolumeN/AAverage Volume3,440 shsMarket Capitalization$157,054.70P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get TransEnterix alerts: Email Address Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! About TransEnterix Stock (OTCMKTS:TRXDW)TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.Read More TRXDW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TRXDW Stock News HeadlinesFebruary 9, 2024 | benzinga.comLife Science Partners L P Synergy's Net WorthJanuary 30, 2024 | investing.comAsensus Surgical Inc (ASXC)May 10, 2024 | Banyan Hill Publishing (Ad)READ THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”January 21, 2024 | ca.finance.yahoo.comTransEnterix, Inc. (TRXDW)June 13, 2023 | finance.yahoo.comSurgical Robots Global Market Report 2023May 27, 2023 | fool.comAsensus Surgical (NYSEMKT: ASXC)February 26, 2023 | msn.comLiberia - Two Ex-Soldiers Claim Massaquoi Was At Waterside, Ordered Killings, RapesOctober 18, 2022 | streetinsider.comAsensus Surgical, Inc. To Present at The LD Micro Main Event XV - StreetInsider.comMay 10, 2024 | Banyan Hill Publishing (Ad)READ THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”September 24, 2022 | seekingalpha.comASXC Asensus Surgical, Inc.September 21, 2022 | finance.yahoo.comOrthopedic Surgical Robots Market is likely to Grow USD 24.22 Billion with Registering a CAGR of 18.1% by 2029, Size, Share, Growth, Emerging Trends, and Regional Overview - Yahoo FinanceSeptember 21, 2022 | globenewswire.comOrthopedic Surgical Robots Market is likely to Grow USD 24.22 Billion with Registering a CAGR of 18.1% by 2029, Size, Share, Growth, Emerging Trends, and Regional Overview - GlobeNewswireSeptember 9, 2022 | stockhouse.com2022-09-09 | NYSEAM:ASXC | Press Release | Asensus Surgical Inc. - StockhouseSeptember 2, 2022 | benzinga.comWith 17.40% CAGR, Surgical Robots Market Size to Worth US$ 26.69 billion by 2030 | Growth Plus Reports - BenzingaAugust 16, 2022 | finance.yahoo.comSpine Surgery Robots Market is Set to Exceed Valuation of USD 139.93 Million with Potential Growth Rate of 8.40% by 2029 | Analyzed by Size Share, Trends, Key Players & Future Growth Outlook - Yahoo FinanceAugust 9, 2022 | streetinsider.comAsensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2022 - StreetInsider.comJune 13, 2022 | globenewswire.comCollaborative Robots Market worth $1671 Million by 2028 with a CAGR of 15.2% - GlobeNewswireApril 14, 2022 | finance.yahoo.comBariatric Surgical Devices Market size worth $ 2223.84 Million, Globally, by 2028 at 9.29% CAGR: Verified Market Research® - Yahoo FinanceFebruary 17, 2022 | finance.yahoo.comRobotic Surgery Services Global Market Report 2022 - Yahoo FinanceFebruary 15, 2022 | finance.yahoo.comSurgical Robots Market Size & Share Report [2021-2026] | Market worth USD 6,875.1 Mn with 21.4% CAGR - Yahoo FinanceFebruary 11, 2022 | businesswire.comGlobal Medical Device Market Outlook 2022-2027: Demographic Drivers, Cultural Shifts and the Pandemic have Supercharged the Medical Device Market - ResearchAndMarkets.com - Business WireOctober 26, 2021 | finance.yahoo.comHere's Why TransEnterix Rallied 47% in 2017October 25, 2021 | prnewswire.comSurgical Robots Market size worth $ 22.27 Billion, Globally, by 2028 at 17.60% CAGR: Verified Market Research® - PRNewswireOctober 9, 2021 | fool.comIs Intuitive Surgical a Buy on the Dip? - Motley FoolAugust 13, 2021 | finance.yahoo.comAlpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors - Yahoo FinanceAugust 4, 2021 | globenewswire.comMedical Robots Market Research Report 2021 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast - GlobeNewswireAugust 4, 2021 | finance.yahoo.comMedical Robots Market Research Report 2021 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast - Yahoo FinanceSee More Headlines Receive TRXDW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TransEnterix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/05/2020Today5/10/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:TRXDW CUSIPN/A CIK876378 Webwww.transenterix.com Phone+1-919-7658400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($4.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-154,200,000.00 Net Margins-2,149.15% Pretax MarginN/A Return on Equity-83.74% Return on Assets-64.94% Debt Debt-to-Equity Ratio0.04 Current Ratio3.24 Quick Ratio2.30 Sales & Book Value Annual Sales$8.53 million Price / Sales0.02 Cash Flow$0.00 per share Price / Cash Flow1.40 Book Value$2.68 per share Price / Book0.00Miscellaneous Outstanding Shares142,777,000Free FloatN/AMarket Cap$157,054.70 OptionableNot Optionable Beta2.56 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Todd M. Pope (Age 53)CEO, Pres & Director Mr. Joseph P. Slattery (Age 53)Exec. VP, CFO & Principal Accounting Officer Mr. Anthony Fernando (Age 46)COO, CTO & Exec. VP Mr. Joshua B. Weingard (Age 45)Chief Legal Officer & Sec. Dr. Stephanie M. Fitts Ph.D. (Age 52)VP of RA/QA, Clinical and Compliance Key CompetitorsObsEvaNASDAQ:OBSVWillistonOTCMKTS:WHCAPredictive Technology GroupOTCMKTS:PREDPeak BioNASDAQ:PKBOAdhera TherapeuticsOTCMKTS:ATRXView All Competitors TRXDW Stock Analysis - Frequently Asked Questions How have TRXDW shares performed in 2024? TransEnterix's stock was trading at $0.05 on January 1st, 2024. Since then, TRXDW shares have decreased by 97.8% and is now trading at $0.0011. View the best growth stocks for 2024 here. How were TransEnterix's earnings last quarter? TransEnterix, Inc. (OTCMKTS:TRXDW) announced its earnings results on Thursday, November, 5th. The medical instruments supplier reported ($0.12) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.11. The medical instruments supplier earned $0.81 million during the quarter, compared to analyst estimates of $0.73 million. TransEnterix had a negative trailing twelve-month return on equity of 83.74% and a negative net margin of 2,149.15%. How do I buy shares of TransEnterix? Shares of TRXDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TRXDW) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransEnterix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
